|
|
Committee on
Energy and Commerce
2125 Rayburn House Office
Building, Washington, DC
20515
Phone: (202) 225-2927 Contact Us »
Home »
|
|
|
Home Page > Responses to April 3, 2008 letter |
Responses to April 3, 2008 letter to 35 groups in regard to generic versions of biologic products
May 2, 2008 |
AARP |
May 2, 2008 |
AFL-CIO |
May 2, 2008 |
American Society of Clinical Oncology |
May 2, 2008 |
Amgen |
May 2, 2008 |
Association of American Universities |
May 2, 2008 |
Barr Pharmaceuticals, Inc. |
May 2, 2008 |
Biogen |
May 2, 2008 |
Biotechnology Industry Organization |
May 2, 2008 |
California Healthcare Institute |
April 21, 2008 |
Cell Therapeutics, Inc. |
May 2, 2008 |
Coalition for a Competitive Pharmaceutical Market |
May 2, 2008 |
Consumers Union |
May 2, 2008 |
Federal Trade Commission |
April 30, 2008 |
General Motors |
|
Genetech |
May 6, 2008 |
GlycoMimetics, Inc. |
|
GPHA |
April 29, 2008 |
Insmed Incorporated |
|
Johnson & Johnson |
May 2, 2008 |
Millennium Pharmaceuticals, Inc. |
May 2, 2008 |
Mylan Labs |
|
National Governors Association |
|
National MS Society |
May 2, 2008 |
National Organization of Rare Disorders |
May 2, 2008 |
National Venture Capital Association |
May 1, 2008 |
Novartis Corporation |
May 2, 2008 |
PhRMA |
|
Teva Pharmaceuticals |
May 2, 2008 |
Vertex Pharmaceuticals Incorporated |
|
|